| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 126.70M | 109.90M | 102.00M | 93.30M | 83.20M |
| Gross Profit | 77.40M | 70.90M | 63.70M | 56.90M | 51.10M |
| EBITDA | 42.20M | 37.50M | 32.90M | 32.50M | 27.70M |
| Net Income | 30.10M | 25.60M | 23.50M | 24.50M | 19.20M |
Balance Sheet | |||||
| Total Assets | 90.70M | 84.70M | 75.10M | 76.50M | 84.00M |
| Cash, Cash Equivalents and Short-Term Investments | 26.40M | 20.50M | 21.80M | 18.70M | 23.10M |
| Total Debt | 9.30M | 9.30M | 8.20M | 9.30M | 17.10M |
| Total Liabilities | 39.00M | 38.50M | 33.10M | 34.50M | 40.60M |
| Stockholders Equity | 51.70M | 46.20M | 42.00M | 42.00M | 43.40M |
Cash Flow | |||||
| Free Cash Flow | 37.50M | 22.80M | 28.80M | 24.90M | 25.40M |
| Operating Cash Flow | 37.90M | 28.40M | 32.20M | 27.20M | 26.70M |
| Investing Cash Flow | -5.40M | -5.40M | -3.10M | -2.30M | -1.30M |
| Financing Cash Flow | -26.40M | -24.10M | -25.80M | -29.70M | -39.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £466.08M | 11.06 | 58.56% | 3.58% | 15.29% | 17.28% | |
74 Outperform | £8.26B | 29.15 | 48.58% | 1.94% | 7.76% | 17.61% | |
70 Outperform | £492.84M | 71.10 | 1.53% | 1.73% | -0.18% | 11.49% | |
68 Neutral | £215.80M | 37.63 | 5.22% | 0.80% | 19.00% | -53.85% | |
63 Neutral | £74.21M | 23.49 | -1.09% | 2.00% | 9.69% | -319.35% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | £132.41M | 15.12 | 7.38% | 1.92% | -7.27% | -15.76% |